June 10, 2024 11:08 AM EDT
News Briefing

Sh­iono­gi inks deal for pre­clin­i­cal hear­ing loss ther­a­pies; Alvotech’s re­fi­nanc­ing pact

ENDPOINTS

Sh­iono­gi li­cens­es hear­ing loss treat­ments in deal up to €400M: The Japan-based phar­ma com­pa­ny paid Cil­care €15 mil­lion ($16.1 mil­lion) up­front …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times